KaiserAB, McGeeZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med1975; 293: 1215.
2.
SchaadUB, McCrackenGHJrPharmacology of LY 127935 (LY) in neonates: relevance to use in neonatal coliform meningitis. Ped Res1980; 14: 564.
3.
FlounioyDJ, PerrymanFA. LY 127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas. Antimicrob Agents Chemother1979; 16: 641.
4.
NeuHC, etal. Antibacterial activity of a new 1-OXA cephalosporin compared with that of other β-lactam compounds. Antimicrob Agents Chemother1979; 16: 141, 528(erratum).
5.
HallWH, etal. Comparative activities of the oxa-β-lactam LY 127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiple, resistant gram-negative bacilli. Antimicrob Agents Chemother1980; 17: 273.
6.
CorderaCS, PekarekRS. Treatment of experimental Haemophilus influenzae type B meningitis with 1-oxa-β-lactam (LY 127935). Antimicrob Agents Chemother1980; 17: 258.
